Establishing a Community-based Framework for ACOs - slide-share 120116Jennifer D.
With the rapid growth of state Medicaid, Medicare, and commercial ACOs, now is the time to establish best practices for addressing the full spectrum of patient needs within an accountable care setting.
How do medicaid waivers expand the possibilities of whole person care 032117Jennifer D.
With the changing landscape in healthcare right now it's important to know how Medicaid Waivers and Whole Person Care can help secure positive outcomes.
Establishing a Community-based Framework for ACOs - slide-share 120116Jennifer D.
With the rapid growth of state Medicaid, Medicare, and commercial ACOs, now is the time to establish best practices for addressing the full spectrum of patient needs within an accountable care setting.
How do medicaid waivers expand the possibilities of whole person care 032117Jennifer D.
With the changing landscape in healthcare right now it's important to know how Medicaid Waivers and Whole Person Care can help secure positive outcomes.
Chapter 3
Toward an Ideal System
Learning Objectives
1. Identify the characteristics of an ideal
long-term care system
2. Describe what it means for the long-term
care system to be consumer-driven
3. Identify the roles of formal and informal
caregivers
Learning Objectives (continued)
4. Define the components of a full and
uniform assessment of a consumer's
service needs
5. Discuss the need for incentives for
providers and consumers
The Criteria for Designing or
Evaluating a Long-Term Care System
What are they?
How were they developed?
How are they used?
Criterion I. The long-term care system should
be based on recognition of the needs, rights,
and responsibilities of individuals.
It should:
A. Be consumer driven
B. Meet all of the needs of the consumers
C. Focus on the individual, recognizing that
individuals have unique needs
D. Respect different cultures and cultural
values
Criterion I (continued)
It should:
E. Promote quality, dignity, and self-
improvement for consumers
F. Balance consumer rights and
responsibilities
G. Offer consumers a choice of service
providers and service delivery modalities
Criterion II. The long-term care system should
be easily accessible.
It should:
A. Be universally accessible
B. Be user friendly
C. Provide care in the least restrictive
environment
D. Encourage single-site care availability
Criterion III. The long-term care system should
coordinate professional, consumer, family, and
other informal caregiver resources.
It should:
A. Integrate professional, community, family,
and other informal caregiver efforts
B. Evolve from the current medical model to
a holistic model of service delivery
C. Involve families in case management and
care delivery
Criterion IV. The long-term care system should
be an integral part of the health and social
system to promote integration, efficiency,
and cost-effectiveness.
It should:
A. Include a full continuum of services
B. Include a full and uniform assessment
(initial and ongoing) of the consumer's
needs.
Criterion IV. (continued)
It should:
C. Provide emphasis on, and reimbursement
for, illness prevention efforts as an
integral part of the overall system
D. Be planned and coordinated to reduce
fragmentation and inefficiencies
E. Be based on outcome-oriented
accountability
Criterion V. The long-term care system should be
adequately and fairly financed.
It should:
A. Utilize public and consumer resources
to ensure universal access to services
B. Provide incentives for consumers to
use services in an appropriate and
cost-effective manner
C. Provide incentives for consumers to
self-finance their care
Criterion V. (continued)
It should:
D. Avoid causing impoverishment of consumers
and families
E. Provide incentives for providers to develop
cost-effective measures
F. Develop payment mechanisms that allow
efficient providers to adequately compen ...
The webinar introduced the Comprehensive Primary Care initiative to the primary care provider community and covered the service delivery model, including the 5 Comprehensive Primary Care functions, and the milestones participating practices will need to achieve in the first year. The process for applying was also discussed, including information about the application itself.
More at: http://innovations.cms.gov/resources/CPCi-Webinar-for-PCPs.html
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
A Best Practice is the belief that there is a technique, method, process, activity, incentive or reward that is more effective at delivering a particular outcome than any other technique, method, process, etc. The idea is that with proper processes, checks, and testing, a desired outcome can be delivered with fewer problems and unforeseen complications.
The purpose of this MPH course unit is to build the capacity (knowledge, skills, and attitudes) of the MPH trainees as future, policy makers, Health Services researchers , planners and health managers at
International, National, regional, district and sub-district levels) who can implement and strengthen health systems in their respective countries
Transforming Clinical Practice InitiativeCitiusTech
The Transforming Clinical Practice Initiative (TCPI) is designed to help small practices and clinicians achieve large-scale health transformation. The initiative is designed to support more than 140,000 clinician practices over four years duration in sharing, adapting and further developing their comprehensive quality improvement strategies. The TCPI is one part of a unique strategy advanced by the Affordable Care Act to strengthen the quality of patient care and manage health care expenditures, ultimately saving the taxpayer from substantial costs. This document describes the initiative in detail with the type of participants, eligibility and reporting requirements of the participants. Understanding the implementation of this initiative not only helps clinicians, but opens up a huge market for Healthcare IT companies offering the products and services like EHR implementation, Integration, EHR/ Data Migration, Implementation of HIE etc.
Chapter 3
Toward an Ideal System
Learning Objectives
1. Identify the characteristics of an ideal
long-term care system
2. Describe what it means for the long-term
care system to be consumer-driven
3. Identify the roles of formal and informal
caregivers
Learning Objectives (continued)
4. Define the components of a full and
uniform assessment of a consumer's
service needs
5. Discuss the need for incentives for
providers and consumers
The Criteria for Designing or
Evaluating a Long-Term Care System
What are they?
How were they developed?
How are they used?
Criterion I. The long-term care system should
be based on recognition of the needs, rights,
and responsibilities of individuals.
It should:
A. Be consumer driven
B. Meet all of the needs of the consumers
C. Focus on the individual, recognizing that
individuals have unique needs
D. Respect different cultures and cultural
values
Criterion I (continued)
It should:
E. Promote quality, dignity, and self-
improvement for consumers
F. Balance consumer rights and
responsibilities
G. Offer consumers a choice of service
providers and service delivery modalities
Criterion II. The long-term care system should
be easily accessible.
It should:
A. Be universally accessible
B. Be user friendly
C. Provide care in the least restrictive
environment
D. Encourage single-site care availability
Criterion III. The long-term care system should
coordinate professional, consumer, family, and
other informal caregiver resources.
It should:
A. Integrate professional, community, family,
and other informal caregiver efforts
B. Evolve from the current medical model to
a holistic model of service delivery
C. Involve families in case management and
care delivery
Criterion IV. The long-term care system should
be an integral part of the health and social
system to promote integration, efficiency,
and cost-effectiveness.
It should:
A. Include a full continuum of services
B. Include a full and uniform assessment
(initial and ongoing) of the consumer's
needs.
Criterion IV. (continued)
It should:
C. Provide emphasis on, and reimbursement
for, illness prevention efforts as an
integral part of the overall system
D. Be planned and coordinated to reduce
fragmentation and inefficiencies
E. Be based on outcome-oriented
accountability
Criterion V. The long-term care system should be
adequately and fairly financed.
It should:
A. Utilize public and consumer resources
to ensure universal access to services
B. Provide incentives for consumers to
use services in an appropriate and
cost-effective manner
C. Provide incentives for consumers to
self-finance their care
Criterion V. (continued)
It should:
D. Avoid causing impoverishment of consumers
and families
E. Provide incentives for providers to develop
cost-effective measures
F. Develop payment mechanisms that allow
efficient providers to adequately compen ...
The webinar introduced the Comprehensive Primary Care initiative to the primary care provider community and covered the service delivery model, including the 5 Comprehensive Primary Care functions, and the milestones participating practices will need to achieve in the first year. The process for applying was also discussed, including information about the application itself.
More at: http://innovations.cms.gov/resources/CPCi-Webinar-for-PCPs.html
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
A Best Practice is the belief that there is a technique, method, process, activity, incentive or reward that is more effective at delivering a particular outcome than any other technique, method, process, etc. The idea is that with proper processes, checks, and testing, a desired outcome can be delivered with fewer problems and unforeseen complications.
The purpose of this MPH course unit is to build the capacity (knowledge, skills, and attitudes) of the MPH trainees as future, policy makers, Health Services researchers , planners and health managers at
International, National, regional, district and sub-district levels) who can implement and strengthen health systems in their respective countries
Transforming Clinical Practice InitiativeCitiusTech
The Transforming Clinical Practice Initiative (TCPI) is designed to help small practices and clinicians achieve large-scale health transformation. The initiative is designed to support more than 140,000 clinician practices over four years duration in sharing, adapting and further developing their comprehensive quality improvement strategies. The TCPI is one part of a unique strategy advanced by the Affordable Care Act to strengthen the quality of patient care and manage health care expenditures, ultimately saving the taxpayer from substantial costs. This document describes the initiative in detail with the type of participants, eligibility and reporting requirements of the participants. Understanding the implementation of this initiative not only helps clinicians, but opens up a huge market for Healthcare IT companies offering the products and services like EHR implementation, Integration, EHR/ Data Migration, Implementation of HIE etc.
The State Innovation Models initiative is a competitive funding opportunity for states to design and test multi-payer payment and service delivery models that deliver high-quality health care and improve health system performance.
- - -
CMS Innovations
http://innovation.cms.gov
We accept comments in the spirit of our comment policy: http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
The Accountable Health Communities Model team hosted a webinar to provide an overview of the new funding opportunity and application requirements for Track 1 on Wednesday, September 14, 2016 from 2:00p.m. – 3:00p.m. EDT.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Patients are receiving disjointed care in the present expensive system. Changing the model:
- Identifying the components of The Transformed System; affordable, accessible, seamless, and coordinated plus high quality, person and family centered, and clinically supportive
- Listing ways to develop partnerships that create strong symbiotic teams
- Creating Care and Operation Interventions that integrate with Care Transitions, Guided Care in the PCMM(H), and ACO models
Similar to Steering Ltc Toward An Ideal System (20)
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Antimicrobial stewardship to prevent antimicrobial resistanceGovindRankawat1
India is among the nations with the highest burden of bacterial infections.
India is one of the largest consumers of antibiotics worldwide.
India carries one of the largest burdens of drug‑resistant pathogens worldwide.
Highest burden of multidrug‑resistant tuberculosis,
Alarmingly high resistance among Gram‑negative and Gram‑positive bacteria even to newer antimicrobials such as carbapenems.
NDM‑1 ( New Delhi Metallo Beta lactamase 1, an enzyme which inactivates majority of Beta lactam antibiotics including carbapenems) was reported in 2008
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYNEHA GUPTA
The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries.
Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks.
Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments.
After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.